PTN Palatin Technologies, Inc.

AMEX
$6.23

Palatin Technologies, Inc. (PTN) is expected to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.32 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -36.8% since its last earnings release on September 28, 2026.

Palatin Technologies Reported Earnings
Monday, September 28, 2026 · 7:30 AM ET
Earnings Date
1st Quarter, Sep 2026
Nov 13
Friday · 7:30 AM ET
Earnings Whisper
-
vs ($0.32)
Rev est $3.93M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.64

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Palatin Technologies, Inc.

Palatin Technologies Inc is a biopharmaceutical company engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.

Sector

Healthcare

Industry

Diagnostic Substances

Charts powered in part by Lightweight Charts™ by TradingView.